GD2
GD2 is a sialic acid-containing glycosphingolipid, and it is made by the Golgi enzyme beta-1,4 N-acetylgalactosaminyltransferase 1, encoded by B4GALNT1 (also known as GalNAc-T, beta1-4GalNAc-T, GALGT and SPG26). The enzyme links GalNAc to precursor gangliosides to build GM2, GD2 and related species. Browse Assay Genie's current range of GD2 research reagents below, or read on for the biology behind the target.
GD2 and GM2 are gangliosides, which are sialic acid-containing glycosphingolipids. Both are synthesised by the enzyme GalNAc-T (beta-1,4 N-acetylgalactosaminyltransferase 1), which catalyses the transfer of GalNAc onto GM3 and GD3 through a beta-1,4 linkage. This reaction produces GM2 and GD2 respectively. UniProt also records a role for the enzyme in the biosynthesis of GT2 and GA2 from GT3 and GA3, so a single activity sits at a branch point in the ganglioside pathway.
The enzyme is a membrane protein located in the Golgi apparatus and belongs to the glycosyltransferase 2 family. HGNC places the gene, B4GALNT1, in the group of beta 4-glycosyltransferases, and the enzyme carries the EC number 2.4.1.92. NCBI Gene reports three transcript variants that encode different isoforms. Orthologues are annotated in mouse and rat as B4galnt1, which allows the pathway to be studied in common model organisms. Researchers working on the GD2 ganglioside itself, on the B4GALNT1 gene or on the GalNAc-T protein are addressing the same biosynthetic step from different angles.
The nomenclature reflects the enzyme's activity. Earlier names include UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase and GALGT. The symbol SPG26 and the previous name spastic paraplegia 26 link the gene to a form of hereditary spastic paraplegia.
GalNAc-T converts GM3 and GD3 into GM2 and GD2, making it a key enzyme for studying how complex gangliosides are built.
GD2 and GM2 are sialic acid-containing glycosphingolipids, so this target is relevant to work on glycolipid structure and synthesis.
As a Golgi membrane glycosyltransferase of the glycosyltransferase 2 family, the enzyme is a model for membrane-bound glycan assembly.
The gene is also designated SPG26, which connects ganglioside biosynthesis to research on spastic paraplegia 26.
GalNAc-T transfers GalNAc to GM3 and GD3 through a beta-1,4 linkage, producing GM2 and GD2. According to UniProt, it is also involved in forming GT2 and GA2 from GT3 and GA3. It acts in the Golgi apparatus membrane.
B4GALNT1 is also called beta1-4GalNAc-T, GALGT, GalNAc-T and SPG26. Earlier descriptive names include UDP-Gal:betaGlcNAc beta-1,4-N-acetylgalactosaminyltransferase transferase 1 and spastic paraplegia 26. NCBI Gene lists three transcript variants that encode different isoforms.
Mouse and rat both have an orthologous gene, B4galnt1. In humans the gene symbol SPG26 and the name spastic paraplegia 26 associate it with a hereditary spastic paraplegia. Check the datasheet of any product for its validated reactivity.
Other ganglioside biosynthesis enzymes, glycosphingolipids and glycosyltransferase targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q00973; product specifications from Assay Genie datasheets.